ORTHOPEDIATRICS CORP Quarterly Selling and Marketing Expense in USD from Q3 2016 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary: Orthopediatrics Corp quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2016 to Q2 2024.
Orthopediatrics Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $16.6M, a 22.6% increase year-over-year.
Orthopediatrics Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $56.1M, a 14.6% increase year-over-year.
Orthopediatrics Corp annual Selling and Marketing Expense for 2023 was $51.4M, a 14.1% increase from 2022.
Orthopediatrics Corp annual Selling and Marketing Expense for 2022 was $45.1M, a 13.6% increase from 2021.
Orthopediatrics Corp annual Selling and Marketing Expense for 2021 was $39.7M, a 24.5% increase from 2020.

Selling and Marketing Expense, Trailing 12 Months (USD)

Selling and Marketing Expense, Quarterly (USD)

Selling and Marketing Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$56.1M	$16.6M	+$3.06M	+22.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$53M	$14.2M	+$1.62M	+12.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$51.4M	$11.7M	+$793K	+7.25%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-08
Q3 2023	$50.6M	$13.6M	+$1.66M	+14%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$48.9M	$13.5M	+$1.1M	+8.87%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	$47.8M	$12.5M	+$2.79M	+28.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$45.1M	$10.9M	+$959K	+9.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-08
Q3 2022	$44.1M	$11.9M	+$2.06M	+20.9%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$42M	$12.4M	+$1.56M	+14.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-01
Q1 2022	$40.5M	$9.76M	+$809K	+9.04%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-02
Q4 2021	$39.7M	$9.99M	+$553K	+5.86%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-08
Q3 2021	$39.1M	$9.86M	+$625K	+6.77%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$38.5M	$10.9M	+$5.26M	+93.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$33.2M	$8.95M	+$1.39M	+18.3%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$31.9M	$9.43M	+$1.07M	+12.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	$30.8M	$9.24M	+$466K	+5.31%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$30.3M	$5.62M	-$1.99M	-26.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$32.3M	$7.56M	+$1.02M	+15.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$31.3M	$8.36M	+$1.8M	+27.5%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-03
Q3 2019	$29.5M	$8.77M	+$1.62M	+22.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$27.9M	$7.61M	+$830K	+12.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$27M	$6.55M	+$468K	+7.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-06
Q4 2018	$26.6M	$6.56M	+$1.16M	+21.4%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-11
Q3 2018	$25.4M	$7.15M	+$1.52M	+26.9%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-08
Q2 2018	$23.9M	$6.78M	+$1.48M	+27.9%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	$22.4M	$6.08M	+$1.89M	+45%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$20.5M	$5.4M			Oct 1, 2017	Dec 31, 2017	10-K	2020-03-05
Q3 2017		$5.63M	+$1.34M	+31.3%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-31
Q2 2017		$5.3M			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017		$4.19M			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q3 2016		$4.29M			Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.